HALEY DAVID: Open Payments
NPI 1366037038 · PORT ALLEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 19 payments from 9 companies in 2025. Trend: 2023 $339 · 2024 $358 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Alkermes, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $32 |
| Novo Nordisk Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: DEXCOM G7 GSS (161), Kerendia, CAPLYTA, REXULTI, ARISTADA, VRAYLAR, Cologuard Collection Kit, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
